Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib/IIa multiple-dose study of HJ178 in healthy volunteers and patients with type 2 diabetes mellitus
CTR20240016Phase 2Active
- Sponsor
- Huajian Future
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HJ178 in type 2 diabetes mellitus (T2DM), sponsored by Huajian Future. Started Jan 2024; status: active.
02
Drugs
HJ178
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20240016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240016.